Prenatal Drug Exposure: Effects on the Adolescent Brain and Behavior Development
| Status: | Archived |
|---|---|
| Conditions: | Psychiatric, Women's Studies |
| Therapuetic Areas: | Psychiatry / Psychology, Reproductive |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | October 2009 |
Prenatal Drug Exposure: Effects on the Adolescent Brain and Behavior Development: Supplementary Control Subjects Recruitment
Background:
- Recent research has suggested that prenatal exposure to drugs may affect specific brain
processes, including working memory, stress response, and decision making. However, most of
the research on the effects of prenatal drug exposure in humans has been conducted early in
life, and very little is known about effects of prenatal drug exposure during the crucial
brain development period that takes place during puberty and adolescence. The biological
and psychological changes associated with puberty may increase adolescents' sensitivity to
prenatal substance exposure. Researchers are interested in using functional magnetic
resonance imaging (fMRI) scans to study brain function and learn more about the effects of
prenatal drug exposure on adolescents.
Objectives:
- To examine the effects of prenatal substance exposure on working memory, decision making,
and normal brain activity in adolescents.
Eligibility:
- Adolescents between 12 and 17 years of age who are enrolled in a larger follow-up study of
children exposed to drugs in utero.
Design:
- The study will involve a single outpatient session with two fMRI scans that will test
working memory and decision-making processes.
- Participants will have brief medical history, a physical examination, and a urine test
for drugs of abuse.
- Participants will then be trained on the working memory and decision-making tasks
before having an initial MRI scan to provide a baseline reading.
- The fMRI scans will take 40 to 45 minutes each, and participants will have break in
between as needed.
Objective- To use fMRI to compare brain activity at rest and during working memory and
decision making tasks in normal children and in children exposed in utero to drugs of abuse.
Study population- All participants will be 12-17 year-olds enrolled in an ongoing
longitudinal follow up study of children exposed to drugs of abuse in utero funded by NIH. A
subgroup of this study cohort will be invited to participate based on added criteria needed
for scanning studies, such as absence of metal in the body, no significant CNS disease, and
ability to tolerate the scanning environment.
Design- Participants will undergo fMRI scans while performing a working memory task, a
decision making task and at rest. Data from participants in the current study will be
combined with those from a previous study (NIDA protocol 417) which now reside in our
repository protocol, 8002.
Outcome measures- The primary outcome measures will be the difference in BOLD fMRI
activation between drug-exposed participants and those without prenatal exposure to drugs of
abuse.
We found this trial at
1
site
Click here to add this to my saved trials
